On the recordJuly 16, 2018
Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 5554) to amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs and generic new animal drugs, as amended. The Clerk read the title of the bill. The text of the bill is as follows: H.R. 5554 Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Animal Drug and Animal Generic Drug User Fee Amendments of 2018''. SEC. 2. TABLE OF CONTENTS; REFERENCES IN ACT. (a) Table of Contents.--The table of contents for this Act is as follows: Sec. 1. Short title. Sec. 2. Table of contents; references in Act. TITLE I--FEES RELATING TO ANIMAL DRUGS Sec. 101. Short title; finding. Sec. 102. Definitions. Sec. 103. Authority to assess and use animal drug fees. Sec. 104. Reauthorization; reporting requirements. Sec. 105. Savings clause. Sec. 106. Effective date. Sec. 107. Sunset dates. TITLE II--FEES RELATING TO GENERIC ANIMAL DRUGS Sec. 201. Short title; finding. Sec. 202. Authority to assess and use generic new animal drug fees. Sec. 203. Reauthorization; reporting requirements. Sec. 204. Savings clause. Sec. 205. Effective date. Sec. 206. Sunset dates. TITLE III--MISCELLANEOUS PROVISIONS Sec. 301. Electronic submissions. Sec. 302. Index of legally marketed unapproved new animal drugs for minor species. Sec. 303. Misbranded drugs and devices. Sec. 304.…





